Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
Clinical trial NCT02701634 · TERMINATED
Trial details
- NCT number
- NCT02701634
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-27
- Primary completion
- 2017-12-19
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.